Artemis DNA Promoted General Counsel, Margaret Kivinski, to Chief Legal Officer and Corporate Secretary

Artemis DNA Promoted General Counsel, Margaret Kivinski, to Chief Legal Officer and Corporate Secretary

Irvine, Calif., November 30, 2021 — Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high complexity clinical diagnostic laboratory company providing proprietary Next Generation Sequencing (NGS) genetic and diagnostic testing that enables precision medicine through early disease detection, announced today the promotion of General Counsel “Margaret’s promotion is the result of many accomplishments she has achieved in the short period of time she has been with Artemis,” commented Emylee Thai, Founder and CEO of Artemis DNA.  “Among many other responsibilities she has worked hard to ensure our regulatory compliance and has been our lead advocate when negotiating complex deals with third parties.  We are lucky to have her and the promotion is well deserved.”

Ms. Kivinski has over two decades of experience in the legal field having worked across various industries but most recently specializing in the biopharmaceutical space.  She earned her undergraduate degree in Chemical Engineering from the University of California Los Angeles and went on to receive her Juris Doctor from Western State University College of Law.  Ms. Kivinski is admitted to state and federal courts in California, the Ninth and Federal Circuit courts of appeal, and is a registered patent attorney with the USPTO.  In her new role, Kivinski will continue to supervise all legal matters for the firm as well as efforts to continue to push Artemis DNA’s sustainability initiatives.

Artemis DNA has been growing at a rapid pace since it launched in 2019.  The firm was founded by Emylee Thai, a serial entrepreneur with a proven history of success who was motivated to start the company by a passion to make innovative, affordable and actionable healthcare solutions accessible to all.


Artemis DNA is a full service, Clinical Laboratory Improvement Amendments (CLIA) certified, College of American Pathologists (CAP) accredited, high-complexity clinical diagnostic laboratory company that provides proprietary Next Generation Sequencing (NGS) genetic testing and diagnostic laboratory services for a wide variety of medical specialties, including cardiology, oncology, immunology, neurology, reproductive health and pharmacogenomics.

Artemis DNA’s testing enhances the delivery of “personalized medicine” by assessing a patient’s own genetic makeup and clinical characteristics which allows for informed decision making in prevention and treatment choices.  Artemis DNA also provides pre- and post-testing genetic education and counseling services, as well as conducting research and development to discover and develop additional novel diagnostic services.  Artemis DNA is headquartered in Irvine, California. For more information, visit https://www.artemisdna.com.



Emylee Thai (Founder and CEO)
Email: pr@artemisdna.com
Phone: (888) 88DNA88, Extension 8


Artemis DNA